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repair capacity may be of benefit in cancer chemotherapy and
may prolong patient’s survival.
Methods: Overall survival (OS) was evaluated in 303 Caucasians
with primary lung cancer who received anticancer treatment that
include first-line chemotherapy using the statistical methods of
Kaplan–Meier curves and Cox proportional hazards model with
hazard ratios (HRs). DNA isolated from peripheral blood was gen-
otyped for XRCC1 (Arg280 His and Arg399Gln) and ERCC2 (Asp312Asn)
by fluorescence-based melting curve (LightCycler) analysis and
for XRCC1 (Arg194Trp) and ERCC2 (Lys751Gln) by PCR-RFLP.
Results: Among all lung cancer cases, only small cell lung cancer
(SCLC) patients carrying the XRCC1 399Arg allele had a reduced
overall survival (HR 2.13, 95%CI 0.92–4.92) compared to the homo-
zygous 399Gln genotype. When compared to XRCC1 Arg280His het-
erozygotes, 280Arg homozygotes showed increased survival being
significant only for SCLC patients (HR 0.31, CI 0.14–0.69). A signif-
icantly increased HR was found for ERCC2 751Gln homozygous car-
riers (HR 3.05, CI 1.20–7.73) for SCLC but not for non-SCLC.
Conclusion: The survival of lung cancer patients receiving che-
motherapy seems to be modified by certain repair gene polymor-
phisms notably in the subgroup of SCLC patients.
doi:10.1016/j.ejcsup.2006.04.112
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Introduction: A histoculture experimental system of colon can-
cer was studied to evaluate the reliability and utility of new bio-
logical approaches. The three-dimensional growth pattern of
the tissue, preserved by this technique is essential for observing
the oncogenic properties, differentiated functions and cellular
heterogeneity of the tumors. Colon cancer as one of the most
common neoplastic diseases worldwide was chosen as a model
for remedial testing with viruses with enhanced oncoselective
activities, as parvovirus H-1. Paralleled in vitro testing of sensitiv-
ity to the oncolytic H-1 parvovirus, using experimental systems of
both cell lines and organotipic cultures of colon cancer, will sup-
port a better prediction of the in vivo response of patient with this
type of cancer.
Methods: Samples from 30 patients with primary untreated
colorectal carcinomas were set in histoculture. This technique
has been reported as a reliable system, in which tumours can
be cultivated with high efficiency by the transfer of human
tumour samples to collagen sponges. H-1 virus in the treated tis-
sue samples and the colon cancer cell lines was detected by IHC
and RT-PCR. Immunofluorescence was used to characterize the
protein patterns of cellular E-cadherin and viral proteins. Tissue
growth inhibition was determined by calculating glucose con-
sumption rates.Results: The analyses revealed significant differences in the
response of the five different human colon cancer cell lines to
H-1 wt parvovirus infectivity and killing abilities. Increased per-
missiveness of the colon cancer cells to virus killing was corre-
lated to the lower expression pattern of E-cadherin. Higher
virus toxicity was measured in colon cancer cells, over-trans-
formed with SV40 large T-antigen. Growth inhibition assays per-
formed in histocultures showed slight reduction on tissue
viability after H-1 wt infection, compared to the stronger effects
after 5-FU treatment. RT-PCR and IHC revealed the presence of
viral transcripts and viral proteins in the samples, which showed
reduced tissue metabolism after infection.
Conclusion: All examined colon cancer cell lines showed a heter-
ogenic response to H-1 parvovirus infectivity. The genetic back-
ground of the cell lines showed that cells characterized as
aneuploid exert better permissivness to virus infectivity. Straight-
forward correlation was observed between the E-cadherin expres-
sion pattern and sensitivity to virus infection. The weak effects
observed after tissue treatment with H-1 wt parvovirus, are due to
the intrinsic cellular heterogeneity of the tumor tissues and confirm
the higher virus oncotropism, with selective killing of the tumor
cells in the original samples, but not their normal counterparts.
doi:10.1016/j.ejcsup.2006.04.113
P54. EXPRESSION ALTERATIONS OF MOLECULAR MARKERS
IN DIFFERENT TYPES OF NSCLC AS A SIGNIFICANT
PROGNOSTIC FACTOR
M. Kochetkova, A. Griazeva, A. Alahverdiev, L. Gurevich, E.
Korsakova, E. Smirnova, I. Zborovskaya. Oncogenes Regulation
Laboratory, Institute of Carcinogenesis, Cancer Research Center,
Moscow, Russia.
Background: The genetic alterations and expression rates of the
molecular markers, associated with prognosis of patients with
lung cancer (LC) were investigated. Biomarker expression levels
were compared in groups of patients with different histological
types and survival rates.
Methods: Tumor samples from 54 patients with NSCLC were
analyzed in a retrospective study of paraffin-embedded tissues
by immunohistochemistry and in fresh frozen biopsies by RT-
PCR. The expression of MMP2, MMP9, b-catenin, E-cadherin,
CAV1, Ki67 were evaluated.
Results: Normal membrane-bound E-cadherin expression was
absent in 80% of the squamous cell LC, 69.2% adenocarcinomas,
85.7% bronchoalveolar carcinomas The normal membrane bound
form of b-catenin was absent almost in all bronchoalveolar carci-
nomas, but it preserved partly in 40% cases of squamous cell LC
and in 53.8% of adenocarcinomas. The MMP2 expression was
common for squamous cell and for bronchoalveolar cancer (60–
71%), but was absent in SCLC. There was no correlation between
the frequency and intensity of expression of adhesion molecules
and proliferation index. The expression of caveolin and RALGDS
was also compared with clinical parameters. The prognostic sig-
nificance of each marker and their complexes was analysed.
Conclusions: Abnormalities in adhesion molecules is common
for different lung carcinomas. Frequency and intensity of expres-
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cation of tumor immunophenotype makes possible to obtain
more data about metastasis potential, malignancy rate and prog-
nosis. This molecular markers panel can be used for early detec-
tion of LC recurring and metastasis.
doi:10.1016/j.ejcsup.2006.04.114
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Background: While in cancer from colon and ovary number and
reactivity of tumor infiltrating lymphocytes (TILs) were associated
with survival, in NSCLC, the clinical significance of TILs is
unknown. While TILs demonstrated antigen specific Interferon
(IFN)-c secretion and cytotoxicity in vitro, their in situ activation
status remains difficult to determine. Here, we examine molecu-
lar assessment of CD8+ T cell reactivity in NSCLC.
Methods: We determined CD8+ T cell counts in 19 patients with
NSCLC by immunohisto-chemistry and assessed T-cell immune
reactivity by measuring mRNA IFN-c levels by quantitative RT-
PCR (TaqMan) from corresponding tissue. CD8+ T cells were clas-
sified into two groups: Intra-tumoral (distributed in cancer cell
nests and stroma) and peri-tumoral (presented along the invasive
margin). Five hpf were evaluated per each localization (IT and PT,
respectively). Distribution of CD8+ T cells was semi-quantitatively
classified into: 0-none or mild; I-moderate; II-severe. The relation-
ship between the median CD8+ T cell density/hpf and the CD8-
normalized IFN-c mRNA expression was tested (Spearman’s
correlation).
Results: Semi-quantitative analysis revealed significantly higher
CD8+ T cell counts within the tumor compared to the invasive
margin (p < 0.001). However, immune activation status of TILs
represented as IFN-c/CD8 ratio was higher in the peri-tumoral
than in the intra-tumoral compartments (p = .022).
Conclusion: In human NSCLC, IFN-c reactivity of CD8+ T cells is
mostly attributed to the tumor–host interface and indicates an
inadequate activation of TILs within the tumor. This methodology
can be applied to a variety of experimental trials if tumor tissue is
available.
doi:10.1016/j.ejcsup.2006.04.115
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of Cologne, Germany.Background: Cyclooxygenase-2 (COX-2) mRNA expression is
known to be progressively increased in the metaplasia–dyspla-
sia–adenocarcinoma (MDA) sequence of Barrett’s cancer (BC)
development. Much less however, is known about COX-2 mRNA
expression in patients with gastroesophageal reflux disease
(GERD).
Methods: Endoscopic biopsies from 3 patient groups were ana-
lyzed: 43 patients undergoing evaluation for GERD (20 GERD posi-
tive/23 GERD negative) by 24-h pH-monitoring, 20 patients with
Barrett’s esophagus (BE) without dysplasia and 47 with BC. COX-
2 mRNA expression was determined by quantitative real-time
RT-PCR (TaqManTM) assays. The Demeester composite score
(DS > 14.72) was used to match COX-2 mRNA expression levels
with the degree of acid exposure.
Results: Median COX-2 mRNA expression was significantly
upregulated in Barrett’s metaplastic epithelium compared to
matched normal squamous epithelium (NE) in the BE (p = 0.03)
and BC group (p = 0.001). COX-2 mRNA expression levels in NE
did not differ significantly between the 3 study groups however,
within the group of patients evaluated for GERD, specimens
obtained from patients with a mean Deemester score >14.72
showed significantly upregulated COX-2 mRNA levels in the distal
acid-exposed esophagus (p = 0.01).
Conclusion: Our findings suggest that the induction of increased
COX-2 mRNA expression occurs already in GERD without the
presence of Barrett’s metaplasia. A field effect as shown for other
genes could not be detected for COX-2 expression in squamous
epithelium in GERD positive, BE or BC patient groups. Chemopre-
vention strategies using selective or non-selective COX-2 inhibi-
tors might be useful in patients with GERD to potentially
prevent the development of Barrett’s metaplasia.
doi:10.1016/j.ejcsup.2006.04.116
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Background: Epidemiological data assume a reduction of risk for
developing an adenocarcinoma of the esophagus for individuals
taking non-steroidal anti-inflammatory drugs. One of the inhib-
ited enzymes, cyclooxygenase-2, is supposed to be involved in
the pathogenesis of Barrett’s cancer. We examined a possible
association between COX-2 protein expression and the progres-
sion of Barrett’s sequence and the type and degree of the environ-
mental inflammatory reaction.
Methods: Squamous epithelium, metaplastic, low-grade and
high-grade dysplastic lesions and tumor tissue of 49 resection
specimens from patients with Barrett’s adenocarcinoma were
analyzed. Immunohistochemical staining was performed with a
